Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Apr-23 5:04 PM View:  | Intellia Therapeutics, Inc. (NTLA) | 14-Apr-23 | Grant | 10,483 | -- | -- | 154% 6.8K to 17.28K | |
| 28-Jun-19 4:47 PM View: | Abbvie Inc. (ABBV) | 26-Jun-19 | Market Purchase | 30,400 | $67.30 | $2,045,920.00 | 22% 139.65K to 170.05K | 41% |
| 04-Mar-19 4:54 PM View: | Abbvie Inc. (ABBV) | 28-Feb-19 | Payment of Exercise | 27,276 | $79.41 | $2,165,990.00 | (16%) 166.93K to 139.65K | (21%) |
| 22-Feb-19 5:20 PM View: | Abbvie Inc. (ABBV) | 21-Feb-19 | Grant | 61,565 | -- | -- | 58% 105.36K to 166.93K | |
| 14-Dec-18 5:12 PM View: | Abbvie Inc. (ABBV) | 12-Dec-18 | Market Sale | 60,000 | $90.00 | $5,400,000.00 | (36%) 165.36K to 105.36K | (8%) |
| 02-Mar-18 5:28 PM View: | Abbvie Inc. (ABBV) | 01-Mar-18 | Option Exercise | 32,400 | $25.91 | $839,339.00 | 20% 165.36K to 197.76K | |
| 02-Mar-18 5:28 PM View: | Abbvie Inc. (ABBV) | 01-Mar-18 | Market Option Sale | 19,000 | $114.50 | $2,175,430.00 | (10%) 197.76K to 178.76K | 18% |
| 02-Mar-18 5:28 PM View: | Abbvie Inc. (ABBV) | 01-Mar-18 | Market Sale | 13,400 | $114.50 | $1,534,250.00 | (7%) 178.76K to 165.36K | 18% |
| 02-Mar-18 5:28 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Payment of Exercise | 28,407 | $118.26 | $3,359,410.00 | (12%) 232.3K to 203.89K | 20% |
| 02-Mar-18 5:28 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Market Option Sale | 13,400 | $119.44 | $1,600,550.00 | (7%) 203.89K to 190.49K | 21% |
| 02-Mar-18 5:28 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Market Sale | 25,128 | $119.44 | $3,001,400.00 | (13%) 190.49K to 165.36K | 21% |
| 16-Feb-18 5:59 PM View: | Abbvie Inc. (ABBV) | 15-Feb-18 | Grant | 48,255 | -- | -- | 26% 184.04K to 232.3K | |
| 19-May-17 5:01 PM View: | Abbvie Inc. (ABBV) | 18-May-17 | Option Exercise | 38,300 | $28.62 | $1,095,990.00 | 21% 184.04K to 222.34K | |
| 19-May-17 5:01 PM View: | Abbvie Inc. (ABBV) | 18-May-17 | Market Option Sale | 38,300 | $65.35 | $2,502,900.00 | (17%) 222.34K to 184.04K | (41%) |
| 02-Mar-17 6:11 PM View: | Abbvie Inc. (ABBV) | 28-Feb-17 | Payment of Exercise | 40,212 | $62.22 | $2,501,990.00 | (18%) 224.26K to 184.04K | (46%) |
| 21-Feb-17 5:50 PM View: | Abbvie Inc. (ABBV) | 16-Feb-17 | Grant | 51,385 | -- | -- | 30% 172.87K to 224.26K | |
| 02-Dec-16 5:08 PM View: | Abbvie Inc. (ABBV) | 02-Dec-16 | Option Exercise | 6,600 | $27.29 | $180,114.00 | 4% 172.87K to 179.47K | |
| 02-Dec-16 5:08 PM View: | Abbvie Inc. (ABBV) | 02-Dec-16 | Market Option Sale | 6,600 | $59.19 | $390,654.00 | (4%) 179.47K to 172.87K | (52%) |
| 02-Mar-16 5:19 PM View: | Abbvie Inc. (ABBV) | 29-Feb-16 | Payment of Exercise | 45,658 | $56.00 | $2,556,850.00 | (21%) 218.53K to 172.87K | (66%) |
| 03-Mar-15 6:05 PM View: | Abbvie Inc. (ABBV) | 28-Feb-15 | Payment of Exercise | 8,192 | $60.50 | $495,616.00 | (4%) 226.72K to 218.53K | (59%) |
| 03-Mar-15 6:05 PM View: | Abbvie Inc. (ABBV) | 27-Feb-15 | Payment of Exercise | 10,299 | $60.52 | $623,296.00 | (4%) 237.02K to 226.72K | (59%) |
| 23-Feb-15 5:08 PM View: | Abbvie Inc. (ABBV) | 19-Feb-15 | Grant | 56,040 | -- | -- | 31% 180.98K to 237.02K | |
| 22-Dec-14 5:22 PM View: | Abbvie Inc. (ABBV) | 22-Dec-14 | Option Exercise | 8,495 | $24.07 | $204,501.00 | 5% 180.57K to 189.06K | |
| 22-Dec-14 5:22 PM View: | Abbvie Inc. (ABBV) | 22-Dec-14 | Market Option Sale | 8,495 | $68.00 | $577,660.00 | (4%) 189.06K to 180.57K | (42%) |
| 04-Mar-14 5:12 PM View: | Abbvie Inc. (ABBV) | 03-Mar-14 | Market Sale | 3,948 | $50.22 | $198,259.00 | (2%) 184.52K to 180.57K | (97%) |
| 04-Mar-14 5:12 PM View: | Abbvie Inc. (ABBV) | 28-Feb-14 | Payment of Exercise | 9,873 | $51.91 | $512,507.00 | (5%) 194.39K to 184.52K | (91%) |
| 24-Feb-14 5:06 PM View: | Abbvie Inc. (ABBV) | 20-Feb-14 | Grant | 53,770 | -- | -- | 38% 140.62K to 194.39K | |
| 20-Dec-13 8:32 PM View: | Abbvie Inc. (ABBV) | 19-Dec-13 | Payment of Exercise | 6,149 | $54.32 | $334,014.00 | (4%) 146.77K to 140.62K | (83%) |
| 20-Dec-13 8:32 PM View: | Abbvie Inc. (ABBV) | 19-Dec-13 | Option Exercise | 7,612 | $34.62 | $263,554.00 | 5% 139.16K to 146.77K | |
| 04-Mar-13 5:09 PM View: | Abbvie Inc. (ABBV) | 28-Feb-13 | Payment of Exercise | 5,260 | $36.73 | $193,200.00 | (4%) 144.42K to 139.16K | (177%) |
| 19-Feb-13 7:06 PM View: | Abbvie Inc. (ABBV) | 19-Feb-13 | Payment of Exercise | 2,912 | $37.58 | $109,433.00 | (2%) 147.33K to 144.42K | (171%) |
| 19-Feb-13 7:06 PM View: | Abbvie Inc. (ABBV) | 14-Feb-13 | Grant | 56,700 | -- | -- | 63% 90.63K to 147.33K | |
| 08-Feb-13 5:04 PM View: | Abbvie Inc. (ABBV) | 07-Feb-13 | Payment of Exercise | 4,188 | $37.14 | $155,542.00 | (4%) 94.82K to 90.63K | (174%) |
| 08-Feb-13 5:04 PM View: | Abbvie Inc. (ABBV) | 07-Feb-13 | Option Exercise | 4,567 | $32.20 | $147,074.00 | 5% 90.25K to 94.82K |